This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
Clinical trial NCT03939364 · WITHDRAWN
Trial details
- NCT number
- NCT03939364
- Sponsor
- Skyline Biosciences
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.